Follow the people · Insider
David Martin Afdahl
David Martin Afdahl files insider transactions with the SEC as a chief operating officer of Ibex. We hold 1 disclosed purchase or sale filed since 12 November 2024, 1 of them in the last 90 days.
- Files forIBEX
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure10 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 8 November 2024 — 8 September 2026Chief Operating Officer · Ibex 14 Form 4 lines · source: SEC Form 4
Every transaction
14 transactions from SEC Form 4 — one row each, sort any column, open a row for the filing| 8 Sep 2026 | 10 Sep 2026SEC Form 4 | 2 d | sold on the open market | Ibex | 17,500 shares | up +7.9% | up +6.8% |
| 31 Jul 2026 | 4 Aug 2026SEC Form 4 | 4 d | was grantednot a trade | Ibex | 2,646 shares | up +12.6% | up +9.8% |
| 31 Jul 2026 | 4 Aug 2026SEC Form 4 | 4 d | had shares withheld for taxnot a trade | Ibex | 1,304 shares | up +12.6% | up +9.8% |
| 1 Jul 2026 | 6 Jul 2026SEC Form 4 | 5 d | had shares withheld for taxnot a trade | Ibex | 1,138 shares | up +25.9% | up +22.0% |
| 26 Feb 2026 | 27 Feb 2026SEC Form 4 | 1 d | was grantednot a trade | Ibex | 4,400 shares | up +36.5% | up +37.7% |
| 26 Feb 2026 | 27 Feb 2026SEC Form 4 | 1 d | was grantednot a trade | Ibex | 4,400 shares | up +36.5% | up +37.7% |
| 6 Feb 2026 | 12 Feb 2026SEC Form 4 | 6 d | was grantednot a trade | Ibex | 109,708 shares | up +13.8% | up +33.6% |
| 6 Feb 2026 | 12 Feb 2026SEC Form 4 | 6 d | had shares withheld for taxnot a trade | Ibex | 13,917 shares | up +13.8% | up +33.6% |
| 6 Feb 2026 | 12 Feb 2026SEC Form 4 | 6 d | was grantednot a trade | Ibex | 109,708 shares | up +13.8% | up +33.6% |
| 6 Feb 2026 | 12 Feb 2026SEC Form 4 | 6 d | had shares withheld for taxnot a trade | Ibex | 13,917 shares | up +13.8% | up +33.6% |
| 2 Oct 2025 | 2 Oct 2025SEC Form 4 | 0 d | sold on the open market | Ibex | 1,103 shares | up +0.7% | up +0.7% |
| 30 Sep 2025 | 2 Oct 2025SEC Form 4 | 2 d | was grantednot a trade | Ibex | 3,228 shares | down −1.8% | up +0.7% |
| 26 Aug 2025 | 15 Sep 2025SEC Form 4 | 20 d | sold on the open market | Ibex | 403 shares | up +36.3% | up +2.4% |
| 8 Nov 2024 | 12 Nov 2024SEC Form 4 | 4 d | was grantednot a trade | Ibex | 4,842 shares | up +103.6% | up +104.3% |
Both percentages are the stock’s move, not David Martin Afdahl’s return: a disclosure gives a band, never an amount, so nobody can say how much was bought or what it made. They run to the last close we hold — 11 Sep 2026, except where a name has since delisted, when the row names its own last session. We publish no close, no volume and no dollar figure behind them. 14 of the 14 rows shown carry a percentage; the rest are dashes with the reason on the row.
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.
Some filings reach us as photographs of paper rather than as a form we can read as text. Those are shown here only once they have been read and checked, so this page can hold fewer lines than the filings behind it contain. The link on every row opens the original document, which is always the full record.